[Elsevier/Sciencedirect] PL03.10 Adjuvant Chemotherapy (CT) vs CT-immunotherapy for R0 Stage IB-IIIA NSCLC Patients (NADIM ADJUVANT): a Randomized, Phase 3 Trial 求助已关闭
|
发布
回复
积分
7300
20
Nanobiotechnology for dendritic cell-based cancer immunotherapy
20
Research progress of DDR1 inhibitors in the treatment of multiple human diseases
20
DDR1-targeted therapies: current limitations and future potential
30
Study of free radicals produced during the pyrolysis of model compounds representing kerogen structural units.
20
Therapeutic strategies for ovarian clear cell carcinoma from a pathogenetic perspective.
